ICD-10-CM Billable Code

H40.60

Glaucoma secondary to drugs, unspecified eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Glaucoma secondary to drugs is a form of eye condition characterized by increased pressure within the eye, which can lead to optic nerve damage and vision loss. This specific type of glaucoma is triggered by certain medications or drug use, and it may affect individuals who are otherwise healthy. Recognizing the causes, symptoms, and available management options can help in early detection and treatment to preserve eye health.

Causes & Symptoms

Clinical Causes: Use of corticosteroids, especially in eye drops, inhalers, or systemic forms Certain medications used for treating inflammatory conditions, allergies, or autoimmune diseases Long-term use of certain psychiatric medications, such as antipsychotics Other drugs that can affect fluid drainage within the eye and increase intraocular pressure

Key Symptoms: Gradual loss of peripheral vision Eye pain or discomfort Redness in the eye Blurry or blurred vision Seeing halos around lights Nausea or vomiting in severe cases

Diagnostic & Treatment

Diagnosis Path: Diagnosing glaucoma secondary to drugs typically involves a comprehensive eye examination, including measuring intraocular pressure (tonometry), visual field testing, and assessment of the optic nerve through ophthalmoscopy. The ophthalmologist will review the patient’s medication history to identify possible drug-induced causes and differentiate this condition from other types of glaucoma.

Treatment Protocols: Management strategies focus on reducing intraocular pressure to prevent further optic nerve damage. Common approaches include: - Discontinuing or substituting the causative medication when possible - Use of eye drops such as prostaglandin analogs, beta-blockers, or alpha agonists - In some cases, laser therapy or surgical procedures may be recommended to improve fluid drainage - Regular monitoring of eye pressure and optic nerve health to track disease progression Collaboration with the healthcare provider to review and adjust medications can be crucial in managing drug-induced glaucoma effectively.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H40.60 a billable ICD-10 code?
Yes, H40.60 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H40.60?
Clinical documentation must specify the nature of Glaucoma secondary to drugs, unspecified eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference